GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma AS (NAS:ASND) » Definitions » Short-Term Debt

ASND (Ascendis Pharma AS) Short-Term Debt : $514.7 Mil (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Ascendis Pharma AS Short-Term Debt?

Ascendis Pharma AS's Short-Term Debt for the quarter that ended in Dec. 2024 was $514.7 Mil.

Ascendis Pharma AS's quarterly Short-Term Debt increased from Jun. 2024 ($488.3 Mil) to Sep. 2024 ($499.1 Mil) and increased from Sep. 2024 ($499.1 Mil) to Dec. 2024 ($514.7 Mil).

Ascendis Pharma AS's annual Short-Term Debt increased from Dec. 2022 ($437.5 Mil) to Dec. 2023 ($459.4 Mil) and increased from Dec. 2023 ($459.4 Mil) to Dec. 2024 ($514.7 Mil).

Ascendis Pharma AS Short-Term Debt Historical Data

The historical data trend for Ascendis Pharma AS's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma AS Short-Term Debt Chart

Ascendis Pharma AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 7.90 437.48 459.40 514.70

Ascendis Pharma AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 459.40 477.60 488.25 499.15 514.70

Ascendis Pharma AS Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Ascendis Pharma AS Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma AS's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Pharma AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma AS (NAS:ASND) » Definitions » Short-Term Debt
Comparable Companies
PCVX JAZZ SRPT TECH EXEL RVMD ROIV MDGL LEGN HALO VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
ASND:Mexico A71:Germany A1SN34:Brazil
Address
Tuborg Boulevard 12, Hellerup, DNK, DK-2900
Website
https://www.ascendispharma.com
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.